Early intensive versus escalation treatment in patients with relapsing-remitting multiple sclerosis in Austria.

Michael GugerChristian EnzingerFritz LeutmezerFranziska Di PauliJörg KrausStefan KalcherErich KvasThomas Bergernull null

Published in: Journal of neurology (2024)

ESC treatment after DMF and TERI revealed a higher relapse and EDSS progression probability compared to EIT in Austrian RRMS patients. Therefore, an early intensive treatment should be started in patients with an active or highly active disease course.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
randomized controlled trial
clinical trial
peritoneal dialysis
systemic lupus erythematosus
disease activity
single cell
replacement therapy
study protocol